Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

BBH Market Vectors Biotech ETF

  • Fund Description

    Market Vectors® Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors U.S. Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.

  •  
      

    • Fund Ticker

      BBH
    • Exchange

      NASDAQ
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVBBHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 02/05/16

    • 30-Day SEC Yield1

      0.35%
    • Total Net Assets

      $513.8M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.40%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/16/2016
  • Portfolio Composition (%)
    as of 02/05/16

    • % of Net Assets
    • Stocks

      100.09
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.09
  • Daily HoldingsDaily Holdings (%) as of 02/05/16

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Gilead Sciences Inc
    GILD US
    849,328
    72,311,78614.07
    Amgen Inc
    AMGN US
    452,897
    65,688,18112.78
    Celgene Corp
    CELG US
    550,604
    53,898,62610.49
    Biogen Idec Inc
    BIIB US
    127,814
    33,725,0026.56
    Baxalta Inc
    BXLT US
    772,648
    29,345,1715.71
    Alexion Pharmaceuticals Inc
    ALXN US
    174,410
    24,815,0554.83
    Regeneron Pharmaceuticals Inc
    REGN US
    58,357
    23,144,9704.50
    Illumina Inc
    ILMN US
    160,752
    21,870,3104.26
    Biomarin Pharmaceutical Inc
    BMRN US
    305,366
    20,890,0884.07
    Vertex Pharmaceuticals Inc
    VRTX US
    238,334
    20,642,1084.02
    Incyte Corp Ltd
    INCY US
    265,689
    18,863,9193.67
    Quintiles Transnational Holdings Inc
    Q US
    290,190
    16,685,9253.25
    United Therapeutics Corp
    UTHR US
    123,440
    14,621,4682.85
    Medivation Inc
    MDVN US
    461,868
    13,458,8342.62
    Qiagen Nv
    QGEN US
    636,662
    13,401,7352.61
    Grifols Sa
    GRFS US
    838,582
    12,821,9192.50
    Alnylam Pharmaceuticals Inc
    ALNY US
    183,389
    12,028,4852.34
    Isis Pharmaceuticals Inc
    IONS US
    273,891
    9,693,0021.89
    Charles River Laboratories Internationa
    CRL US
    113,521
    7,953,2811.55
    Alkermes Plc
    ALKS US
    226,175
    7,276,0501.42
    Seattle Genetics Inc
    SGEN US
    210,232
    6,695,8891.30
    Cepheid Inc
    CPHD US
    190,117
    5,285,2531.03
    Intercept Pharmaceuticals Inc
    ICPT US
    43,256
    4,261,1490.83
    Bluebird Bio Inc
    BLUE US
    75,124
    3,585,6690.70
    Puma Biotechnology Inc
    PBYI US
    32,596
    1,294,7130.25
    Other/Cash
    --
    --
    -440,660-0.09
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.